Please enable Javascript
Gerhardt Attard, MD, PhD
Articles by Gerhardt Attard, MD, PhD
AMPLITUDE: Niraparib, Abiraterone Acetate, Prednisone for mCSPC Patients With HRR Alterations
Gerhardt Attard, MD, PhD
mCSPC
|
June 20, 2025
Dr. Attard explores how the study's results compare with prior data in the metastatic castration-resistant setting.
View More
Use of the Decipher Score and Treatment Intensification During the STAMPEDE Study
Gerhardt Attard, MD, PhD
Prostate Cancer
|
October 1, 2024
Dr. Gerhardt Attard discusses the benefits of the Decipher score as utilized during the STAMPEDE trial.
View More
Determining the Right Patients for Docetaxel Treatment
Gerhardt Attard, MD, PhD
Prostate Cancer
|
October 1, 2024
The Decipher score demonstrated a notable benefit in predicting patient survival rates during the STAMPEDE trial.
View More
Dr. Gerhardt Attard on the STAMPEDE Study for Metastatic Prostate Cancer
Gerhardt Attard, MD, PhD
Prostate Cancer
|
October 1, 2024
Dr. Gerhardt Attard provides insight on the STAMPEDE study, along with the Decipher score used during the trial.
View More